Bolt Biotherapeutics Inc.
BOLT | NASDAQ
$3.57
-$0.02 (-0.56%)
Sep 22, 2026, 11:23 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 4.7M | 6.5M | 7.7M | 5.2M | 4.17M | 3.64M | 7.69M | 9.78M | 11.17M | 11.32M | 7.88M | 7.2M | 6.78M | 6.74M | 5.73M | 4.83M | 3.47M | 2.07M | 1.26M | 752K | n/a | 67K |
Cost of Revenue | 203K | 203K | n/a | 426K | 14.21M | 29.64M | 30.1M | 46M | 47.16M | 47.38M | 61.54M | 62.07M | 66.09M | 69.36M | 73.12M | 78.76M | 79.13M | 79.91M | 75.66M | 68.04M | 58.24M | 47.7M |
Gross Profit | 4.5M | 6.3M | 7.7M | 4.77M | -10.04M | -26.01M | -22.41M | -36.22M | -36M | -36.05M | -53.67M | -54.87M | -59.31M | -62.62M | -67.39M | -73.94M | -75.66M | -77.84M | -74.4M | -67.28M | -58.24M | -47.63M |
Operating Income | -29.28M | -30.12M | -34.63M | -44.7M | -53.44M | -66.82M | -71.8M | -75.9M | -77.64M | -74.87M | -76.2M | -77.47M | -81.63M | -84.86M | -90.32M | -96.36M | -97.54M | -98.24M | -92.79M | -82.64M | -71.51M | -58.86M |
Interest Income | 1.3M | 1.72M | 2.5M | 3.11M | 3.9M | 4.7M | 5.26M | 6.14M | 6.8M | 7.17M | 7M | 6.18M | 4.84M | 3.46M | 2.22M | 1.18M | 724K | 505K | 363K | 375K | 268K | 143K |
Pretax Income | -28.74M | -29.58M | -33.38M | -42.68M | -50.71M | -63.35M | -63.12M | -65.09M | -66.17M | -63.03M | -69.2M | -71.29M | -76.79M | -81.4M | -88.1M | -95.26M | -96.89M | -97.82M | -98.59M | -102.47M | -89.08M | -76.55M |
Net Income | -28.74M | -29.58M | -33.38M | -42.68M | -50.71M | -63.35M | -63.12M | -65.09M | -66.17M | -63.03M | -69.2M | -71.29M | -76.79M | -81.4M | -88.1M | -95.26M | -96.89M | -97.82M | -98.59M | -102.47M | -89.08M | -76.55M |
Selling & General & Admin | 11.67M | 12.77M | 13.8M | 14.63M | 15.09M | 16.45M | 18.46M | 20.04M | 22M | 22.75M | 22.53M | 22.6M | 22.33M | 22.24M | 22.93M | 22.42M | 21.88M | 20.4M | 18.39M | 15.35M | 13.28M | 11.23M |
Research & Development | 21.3M | 23.65M | 28.53M | 34.84M | 42.09M | 50.03M | 56.59M | 61.61M | 62.78M | 62.99M | 61.54M | 62.07M | 66.09M | 69.36M | 73.12M | 78.76M | 79.13M | 79.91M | 75.66M | 68.04M | 58.24M | 47.7M |
Other Expenses | 808K | n/a | n/a | n/a | -13.79M | -25.65M | -25.65M | -41.98M | -43.14M | -46.92M | -61.54M | -62.07M | -66.09M | -69.36M | -73.12M | -78.76M | -79.13M | -79.91M | -75.66M | -68.03M | -58.24M | -47.7M |
Operating Expenses | 33.78M | 36.42M | 42.33M | 49.47M | 43.39M | 40.82M | 49.39M | 39.68M | 41.64M | 38.82M | 22.53M | 22.6M | 22.33M | 22.24M | 22.93M | 22.42M | 21.88M | 20.4M | 18.39M | 15.35M | 13.28M | 11.23M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 82K | 82K | 82K | 82K | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 33.98M | 36.62M | 42.33M | 49.89M | 57.6M | 70.46M | 79.49M | 85.68M | 88.8M | 86.2M | 84.07M | 84.67M | 88.42M | 91.6M | 96.05M | 101.18M | 101M | 100.31M | 94.05M | 83.39M | 71.51M | 58.93M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.69M | 1.87M | 1.87M | 1.92M | 1.92M | 1.92M | 1.91M | 1.91M | 1.91M | 1.9M | 1.9M | 1.89M | 1.89M | 1.88M | 1.88M | 1.87M | 1.86M | 1.86M | 1.86M | 1.86M | 1.83M | 1.71M |
Shares Outstanding (Diluted) | 1.69M | 1.87M | 1.87M | 1.92M | 1.92M | 1.92M | 1.91M | 1.91M | 1.91M | 1.9M | 1.9M | 1.89M | 1.89M | 1.88M | 1.88M | 1.87M | 1.86M | 1.86M | 1.86M | 1.86M | 1.83M | 1.71M |
EPS (Basic) | -16 | -15.89 | -12.31 | -8.89 | -5.57 | -1.67 | -1.66 | -1.71 | -1.74 | -1.66 | -1.79 | -1.82 | -1.97 | -2.09 | -2.31 | -2.54 | -2.59 | -2.63 | -2.71 | -2.95 | -3.03 | -3.18 |
EPS (Diluted) | -16 | -15.89 | -12.31 | -8.89 | -5.57 | -1.67 | -1.66 | -1.71 | -1.74 | -1.66 | -1.79 | -1.82 | -1.97 | -2.09 | -2.31 | -2.54 | -2.59 | -2.63 | -2.71 | -2.95 | -3.03 | -3.18 |
EBITDA | -27.82M | -28.49M | -32.09M | -41.22M | -49.1M | -59.46M | -59.17M | -61.1M | -62.16M | -61.18M | -67.34M | -69.44M | -74.97M | -79.62M | -86.43M | -93.61M | -95.38M | -96.46M | -91.29M | -81.28M | -70.41M | -58.08M |
EBIT | -28.74M | -29.58M | -33.38M | -42.68M | -50.71M | -61.18M | -60.96M | -62.92M | -64M | -63.03M | -69.2M | -71.29M | -76.79M | -81.4M | -88.1M | -95.18M | -96.81M | -97.73M | -92.48M | -82.33M | -71.34M | -58.86M |
Depreciation & Amortization | 919K | 1.1M | 1.29M | 1.46M | 1.61M | 1.72M | 1.78M | 1.82M | 1.84M | 1.85M | 1.85M | 1.85M | 1.83M | 1.78M | 1.67M | 1.57M | 1.43M | 1.28M | 1.19M | 1.05M | 928K | 782K |
Add to Watchlist
Select watchlists to add or remove BOLT